Founder and board member subscribes for shares in the ongoing rights issue
Peter Egelberg, founder and Board member of Phase Holographic Imaging PHI AB (“PHI” or the “Company”) has notified the Company that he, together with closely related parties, follows Altium SA’s lead by subscribing for shares in the Company’s ongoing fully secured rights issue. The subscription amounts to approximately 300 TSEK.
Peter Egelberg, founding Board Member of PHI, comments
“The lack of robust automation has long limited the use of microscopy in manufacturing environments. Since resigning as CEO, I have gone back to my roots in software development, AI, physics and mathematics to solve this long-standing problem. Together with the PHI development team, I have now spent nearly two years improving HoloMonitor’s QPI technology. The results have convinced me that PHI will soon be able to offer unprecedented automation of image-based cell analysis for applications in medical research, biomanufacturing and clinical regenerative medicine, which is bound to attract attention in the life science industry.”
Advisors
Navia Corporate Finance AB is the financial advisor and Sole Bookrunner in connection with the rights issue. HWF Advokater AB is the legal advisor. Nordic Issuing AB is the issuing agent.
For more information about the rights issue, please contact:
Navia Corporate Finance AB
E-mail: info@naviacf.se
Website: www.naviacorporatefinance.com
For additional information, please contact:
Anders Månsson
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis
Subscribe to PHI news on cision.com
